SEC Tracker
Get the app

Aptevo Therapeutics APVO

Aptevo extends Rights Agreement

Item 1.01 Enters material agreement, Item 3.03 Changes shareholder rights

Form
8-K
Filed
Importance
Major
  1. Amendment No. 6 extends Final Expiration Date to Oct 23, 2027
  2. Purchase Price set at $14.56 per one one-thousandth of a Preferred Share
  3. Amendment attached as Exhibit 4.1

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Aptevo Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Traws Pharma ONTX public float $10M, Jun 30, 2025
  2. Mannatech MTEX public float $10M, Jun 30, 2025
  3. LeonaBio ATHA public float $10M, Jun 30, 2025
  4. BioCardia BCDA public float $10M, Jun 30, 2025
  5. Alaunos Therapeutics TCRT public float $10M, Jun 30, 2025